Scope:
Keywords:
Update

News on companies and Eisai.Eu

254 days ago

Analyze the latest news on companies and Eisai.Eu, extract the entire dataset or get visualizations.

Related dashboards:

Latest news

Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says

Read on: CNBC News link
254d ago

European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai

Read on: CNBC News link
262d ago

After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen

Read on: ABC News link
569d ago

Extract data

Extract all the news on this scope:

Visualize data

Trend on this scope:

Evolution through time

Source analysis:

Distribution of sources in the news

Section analysis:

Distribution of sections in the news

Current sentiment polarity: slightly positive (0.38)

positive 67%
negative 33%

Sentiment polarity through time